Product hopping 2.0: getting the FDA to yank your original license beats stacking patents.

This document cites

• Federal Cases - 211 F.3d 21 (2nd Cir. 2000), 99-9501, SmithKline Healthcare v Watson Pharmaceuticals
• Federal Cases - 98 F.Supp.2d 362 (S.D.N.Y. 2000), 99 Civ. 3658, Purdue Pharma L.P. v. Boehringer Ingelheim GmbH
• Federal Cases - 288 F.3d 141 (4th Cir. 2002), 01-2206, Sigma-Tau Pharmaceuticals, Inc. v. Schwetz
• Federal Cases - 292 F.Supp.2d 1346 (S.D.Fla. 2003), 018726, Labzda v. Purdue Pharma, L.P.
• Federal Cases - 495 F.Supp.2d 569 (W.D.Va. 2007), 1 07CR00029, United States v. Purdue Frederick Co., Inc.



See all quotations

• Federal Cases - 592 F.3d 991 (9th Cir. 2010), 08-56314, Allied Orthopedic Appliances Inc. v. Tyco Health Care Group LP
• Federal Cases - 432 F.Supp.2d 408 (D.Del. 2006), Civ. A. 02-1512, Abbott Laboratories v. Teva Pharmaceuticals USA, Inc.
• Federal Cases - 237 F.3d 1359 (Fed. Cir. 2001), 00-1398, Purdue Pharma v. Boehring Ingelheim
• Federal Cases - 339 F.3d 1373 (Fed. Cir. 2003), 02-1540, Schering Corp. v. Geneva Pharmaceuticals
• Federal Cases - 438 F.3d 1123 (Fed. Cir. 2006), 04-1189, Purdue Pharma L.P. v. Endo Pharmaceuticals, Inc.
• Federal Cases - 686 F.3d 813 (D.C. Cir. 2012), 11-5028, Friedman v. Sebelius
• Federal Cases - 611 F.3d 1381 (Fed. Cir. 2010), 2010-1105, Sun Pharmaceutical Industries, Ltd. v. Eli Lilly and Co.
• Federal Cases - 91 F.3d 1493 (D.C. Cir. 1996), 95-5399, Bristol-Myers Squibb Co. v. Shalala
• Federal Cases - 534 F.Supp.2d 146 (D.D.C. 2008), C. A. 06-2084, Walgreen Co. v. AstraZeneca Pharmaceuticals L.P.
• Federal Cases - 889 F.Supp.2d 119 (D.D.C. 2012), C. A. 12-1105 (ABJ), K-V Pharmaceutical Co. v. U.S. Food and Drug Admin.
• Federal Cases - 898 F.Supp.2d 227 (D.D.C. 2012), 1:11-CV-0907, ISTA Pharmaceuticals, Inc. v. Food and Drug Administration
• Federal Cases - 981 F.Supp.2d 38 (D.D.C. 2013), C. A. 12-01842 (RBW), Cumberland Pharms. Inc. v. Food & Drug Administration
• Federal Cases - 499 U.S. 365 (1991), 89-1671, City of Columbia v. Omni Outdoor Advertising, Inc.
• Pennsylvania - 74 A.3d 221 (Pa.Super. 2013), 83 EDA 2012, In re Reglan/Metoclopramide Litig.